From the manual method of Topliss to a modified quantitative method

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 2, 2002, Pages 125-132

  Yunes, Rosendo A ^a   Fonseca Heinzen, Vilma E ^a   Cechinel Filho, Valdir ^a   Lazzarotto, Marcelo ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Drug design; Quantitative structureactivity relationship; Structure activity relationship; Topliss method, modified

Indexed keywords

AROMATIC COMPOUND; LEAD;

ARTICLE; CALCULATION; CHEMICAL MODIFICATION; CLINICAL RESEARCH; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HYDROPHOBICITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; STEREOCHEMISTRY; TECHNIQUE;

EID: 0036167037     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299868     Document Type: Article

References (38)

1. Exploring organic synthetic experimental procedures
2. Interdependence between physical parameters and selection of substituent groups for correlation studies
3. A manual method for applying the Hansch approach to drug design
4. Comparative Molecular-Field Analysis (COMFA). 1. Effect of shape on binding of steroids to carrier proteins
5. Construction of 3D-QSAR models using the 4D-QSAR analysis formalism
6. Development of a predictive statistical model for the analgesic activity of a family of imides
7. Examination of the utility of the Topliss schemes for analog synthesis
8. Utilization of operational schemes for analog synthesis in drug design
9. Cautions regarding physical interpretation of statistically based structure-activity relationships
10. The use of substituent constants in the study of structure-activity relationships in cholinesterase inhibitors
11. Inhibition of phenethanolamine N-methyl transferase by ring-substituted alpha-methylphenethylamines (amphetamines)
12. Quantitative structure-activity relationships and molecular graphics in ligand receptor interactions: Amidine inhibition of trypsin
13. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines
14. Structure-activity relationship in synthetic fibrinolytics. 2-Phenethynyl-cyclopropane-carboxylates
15. Biological activities of drugs. VII. Structure-activity relationship of sulfonamide carbonic anhydrase inhibitors
16. Acylation of chymotrypsin by active esters of nonspecific substrates. Evidence for a transient acylimidazole intermediate
17. Quantitative structure-activity relationships of 6-anilinouracils as inhibitors of Bacillus subtilis DNA polymerase III
18. Irreversible enzyme inhibitors. CVII. Proteolytic enzymes. II. Bulk tolerance within chymotrypsin-inhibitor complexes
19. Structure-activity relationship in benzamides inhibiting alochol dehydrogenase
20. Inhibition of prostaglandin biosynthesis by 2-aryl-1,3-indandiones
21. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazines
22. Papain hydrolysis of X-phenyl-N-methanesulfonyl glycinates: A quantitative structure-activity relationship and molecular graphics analysis
23. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships
24. Structure-activity relationships of monoamine oxidase inhibitors
25. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-di-hydro-2, 2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis
26. The structure-activity relationship of 9-(X-phenyl)guanine inhibitors of xanthine oxidase
27. Synthesis and antiinflammatory activity of some aryltetrazolylalkanoic acids
28. Synthesis and hypoglycemic activity of phenacyltriphenylphosphoranes and phosphonium salts
29. Correlation analysis of Baker's studies on enzyme inhibition. 1. Guanine deaminase, xanthine oxidase, dihydrofolate reductase, and complement
30. Antiallergic activity of 2-phenyl-8-azapurin-6-ones
31. Quantitative structure-activity relationship of 5-(X-benzyl)-2,4-diaminopyrimidines inhibiting bovine liver dihydrofolate reductase
32. Quantitative models of steric effects
33. Pattern recognition study of QSAR substituent descriptors